← SynDRA
R-1487
SynDRA canonical compound SYN0024152 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MAPK14 |
| Mechanism of action | p38 MAPK inhibitor |
All known targets
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
Cross-references
Synonyms
- 6-(2,4-difluorophenoxy)-8-methyl-2-((tetrahydro-2H-pyran-4-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
- UNII-IO0DCY55NQ
- IO0DCY55NQ
- CHEMBL1230122
- 6-(2,4-difluorophenoxy)-8-methyl-2-[(tetrahydro-2H-pyran-4-yl)amino]-Pyrido[2,3-d]pyrimidin-7(8H)-one
- 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2h-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8h)-one
- Kinome_3762
- SCHEMBL5120612
- KKKRKRMVJRHDMG-UHFFFAOYSA-N
- HMS3401C13
- BDBM50341342
- ZINC58633224
- AKOS027420928
- NCGC00262195-02
- KB-80224
- ACM449811921
- RefChem:178450
- R1487 cpd
- orb1299610
- SCHEMBL29527296
- ZSA81192
- EX-A14324
- NSC767348
- EBC-224062
- NSC-767348
- SDCCGRCH-0000039.P001
- NCGC00262195-03
- DB-070615
- CS-0003671
- T7667
- R1487?
- 3FN
- 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-D]pyrimidin-7(8H)-one
- R1487 HCl
- R1487
- R1487 (Hydrochloride)
- 6-(2,4-Difluorophenoxy)-8-methyl-2-[(tetrahydro-2H-pyran-4-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride
- R 1487 HYDROCHLORIDE
- C19H19ClF2N4O3
Look up R-1487 in the interactive SynDRA portal →